The Hanover Insurance Group Reports Record Second Quarter 2026 Results

Key Highlights for Investors

• Record Net Income and Operating Income: Q2 net income of \$191.6 million (\$5.38 per diluted share), operating income of \$189.2 million (\$5.31 per diluted share), both marking second quarter records.
• Exceptional Return on Equity: Net and operating ROE reached 21.2% and 19.8%, respectively, for the quarter. Book value per share rose to \$105.40, up 3.5% from March 31, 2026.
• Strong Underwriting Performance: Combined ratio of 91.2%; excluding catastrophe losses, combined ratio was 85.5%. Catastrophe losses were \$91.8 million, accounting for 5.7 points of the combined ratio.
• Premium Growth: Net premiums written increased 4.6% year-over-year. Renewal price increases were 8.7% in Personal Lines, 7.8% in Core Commercial, and 3.6% in Specialty. Rate increases were also robust: 7.0% in Core Commercial, 4.8% in Personal Lines, and 2.1% in Specialty.
• Investment Income: Net investment income reached \$119.6 million, up 13.4% from the prior-year quarter, driven by higher earned yields and strong operating cash flows.
• Share Repurchases: The company repurchased approximately 291,000 shares (\$55 million) in Q2. Year-to-date through July 24, 2026, repurchases total 827,000 shares (\$149 million). There remains \$660 million under the new \$700 million authorization.
• Leadership Transition: CEO John C. Roche announced his planned retirement at the end of 2026. Dick Lavey, a key architect of the company’s strategy, will succeed Roche as CEO.

Detailed Financial Overview

Premiums and Profitability

Segment Results

• Core Commercial: Net premiums written up 2.6% to \$697.6 million. Combined ratio improved to 88.9% from 95.5%.
• Specialty: Net premiums written up 4.4% to \$384.4 million. Combined ratio 88.3% (vs. 86.5% prior year).
• Personal Lines: Net premiums written up 7.2% to \$574.8 million. Combined ratio 95.7% (vs. 93.0% prior year).

Investment Portfolio

• Net investment income increased to \$119.6 million due to higher yields and cash flow.
• Portfolio size: \$11.2 billion in cash and invested assets at June 30, 2026. Fixed maturities and cash comprise 93% of portfolio; 95% investment grade.
• Unrealized losses on fixed maturities: \$259.5 million pre-tax at June 30, up from \$235.6 million at March 31.

Balance Sheet and Capital Actions

• Statutory capital and surplus: \$3.54 billion (slightly higher than previous quarter).
• Book value per share (ex-unrealized losses): \$111.26, up 3.8% from March 31.
• Share repurchases: Significant activity in Q2 and YTD, with remaining capacity for further buybacks.

Strategic and Leadership Update

• The Hanover will host a virtual strategic outlook and financial update on September 17, 2026, to discuss its next chapter, strategic priorities, and updated long-term financial targets, including a Q&A with the executive team.
• CEO succession is a major event: John C. Roche retiring after nine years, with Dick Lavey taking over—this leadership change could impact investor sentiment.

Potential Price-Sensitive Information for Shareholders

• Record earnings and ROE: Strong financial performance and premium growth may positively influence share price.
• Share repurchase program: Significant repurchases and large remaining authorization are supportive of share value.
• Leadership transition: CEO change at end of 2026; succession planning and strategic vision continuity may affect investor confidence.
• Investment portfolio: Increase in unrealized losses on fixed maturities may warrant attention if market conditions worsen.
• Upcoming strategic update: September event may announce new financial targets, strategic direction—potential for material news.

Forward-Looking Statements and Non-GAAP Measures

The company’s outlook includes forward-looking statements regarding growth, reserve strength, and performance for the remainder of 2026 and beyond. These statements are not guarantees and actual results may differ materially. Investors should review the company’s filings for risk factors.

The Hanover uses non-GAAP measures such as operating income, operating ROE, and book value per share excluding unrealized losses. Details of these calculations and reconciliations to GAAP measures are provided in the report. These metrics are intended to give insight into the performance of core operations, but should not be considered substitutes for GAAP results.

Upcoming Investor Events

• Q2 earnings conference call: July 29, 10:00 a.m. ET
• Virtual strategic outlook and financial update: September 17, 10:00 a.m. ET

Contact Information

• Investor Relations: Oksana Lukasheva ([email protected]), 1-508-525-6081
• Media: Emily P. Trevallion ([email protected]), 1-508-855-3263

Disclaimer: This article summarizes financial results and significant events for The Hanover Insurance Group as reported in its Q2 2026 earnings release. It contains forward-looking statements, which are subject to risks and uncertainties. Investors should review official company filings and consult with financial advisors before making investment decisions. This article does not constitute investment advice.

View HANOVER INSURANCE GROUP, INC. Historical chart here